impower010: adjuvant atezolizumab improves dfs in resected stage ii-iiia nsclc
Published 3 years ago • 522 plays • Length 4:50Download video MP4
Download video MP3
Similar videos
-
2:44
disease-free survival in impower010 trial: adjuvant atezolizumab in nsclc
-
3:17
impower010: os results of atezolizumab vs best supportive care in resected nsclc
-
1:41
adjuvant atezolizumab in nsclc
-
4:48
keynote-091 and impower010: adjuvant chemotherapy for nsclc
-
7:36
dr bhuvan | impower010 adjuvant atezolizumab after adjuvant chemotherapy in resected stage ib iiia
-
9:24
impower010 supports adjuvant atezolizumab in early-stage nsclc | heather wakelee
-
8:20
impower010: atezolizumab versus best supportive care after adjuvant chemotherapy in resected nsclc
-
3:27
#esmo21 highlights on patterns of relapse in nsclc to atezolizumab vs bsc after adj ct: impower010
-
14:00
asco 2021 lung recap: impower010: atezolizumab after chemo in non-small cell lung cancer
-
15:00
podcast 299: lung cancer and atezolizumab — results from the impower010 trial
-
3:02
neoadjuvant and adjuvant immunotherapy in non-small cell lung cancer
-
21:02
what did we learn from impower010 in resectable nsclc? - medpage today
-
5:41
javelin lung100, primus, nintnivo, impower010: investigating io in nsclc
-
3:44
immunotherapy as combination and neoadjuvant therapies in nsclc
-
1:39
lcmc3: adjuvant and neoadjuvant atezolizumab in early-stage ncslc
-
4:18
impower110: atezolizumab vs chemo in pd-l1–selected nsclc
-
3:07
neoadjuvant atezolizumab in nsclc
-
2:36
imvigor010 & imvigor011: ctdna as a response biomarker for adjuvant atezolizumab in high-risk mibc
-
6:09
impower010: a phase 3 study of atezolizumab vs best supportive care after adjuvant chemotherapy ...